C. Anthony Altar, PhD
Company: Splice Therapeutics
Job title: President and Chief Operating Officer
Seminars:
Advantages of RNA Trans-splicing for Editing Inherited & Acquired Mutations that Cause Disease 4:15 pm
day: Conference Day One